Dublin, Sept. 23, 2020 (GLOBE NEWSWIRE) -- The "Global Emerging Sleep Apnea Devices and Platforms Market: Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
Global Emerging Sleep Apnea Devices and Platforms Market to Reach $13.18 Billion by 2030
Key Questions Answered in this Report:
How has the COVID-19 pandemic impacted the global emerging sleep apnea devices and platforms market?
Is the usage of continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo-ventilators (ASV) as clinical ventilators a sustainable solution for the post-COVID-19 scenario?
How can the market cater to global healthcare system requirements such as remote patient monitoring, constant collection of clinical data, and clinical data management and its analysis?
What is the global regulatory landscape pertaining to the global emerging sleep apnea devices and platforms market? How have the regulations altered owing to the COVID-19 pandemic?
What has been the patent landscape for the market during 2017-2020? How has the COVID-19 pandemic impacted the patent scenario?
What are the major companies operating in the market and their respective market share?
What are the major strategies employed by the companies to enter the market or for business expansion?
How are the emerging sleep apnea devices and platforms different from conventional sleep apnea devices?
What are the pipeline products and their analysis for the market?
What are the major industry trends, market drivers, and market restraints that would impact the market during the forecast period 2021-2030? What are the growth opportunities for the market?
What therapeutic and diagnostic devices and platforms are expected to witness the highest growth during the forecast period 2021-2030?
Which end-user segment is expected to lead the market during the forecast period 2021-2030?
What would be the country-level revenue share and CAGR for the market during the forecast period 2021-2030?
Which emerging countries have immense opportunities for the growth and adoption of sleep apnea devices and platforms? Would the scenario continue for the next five years?
Where will the advancements in technology offered by various companies take the industry in the mid to long term?
What are the upcoming alternative therapies and associated devices for sleep apnea treatment?
The global emerging sleep apnea devices and platforms market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $4,882.2 million in FY2019, and it is expected to grow at a CAGR of 9.94% during the forecast period, 2021-2030. Presently, more than 45 companies are operating in this market, including already existing healthcare companies and emerging healthcare companies.
Moreover, during COVID-19 pandemic, various regulatory agencies such as Food and Drug Administration (FDA), U.S. and Therapeutic Goods Administration (TGA) have approved the usage of positive airway pressure (PAP) devices such as continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo ventilators (ASVs) as ventilators. Additionally, the demand for oral appliances has also increased significantly due to the high risk of infection in the case of COVID-19 positive sleep apnea patients.
In the situation, the usage of a PAP device can increase the risk of infection for the patient's peers. Other devices with increased demand included home sleep testing devices and sleep apnea screening and monitoring devices and solutions. In addition to conventional devices, emerging therapeutic and diagnostic and monitoring devices have also witnessed a significant increase in demand.
Our healthcare experts are continuously analyzing the impact of regulatory and industrial decisions on the global emerging sleep apnea devices and platforms market. The market is driven by certain factors, including growing awareness regarding the ill effects of untreated sleep apnea, increasing usage of oral appliances for sleep apnea treatment, rising demand for portable sleep apnea devices, and technological advancements in sleep apnea treatment and diagnosis devices and platforms.
The market is favored by the development of emerging therapeutics and diagnostic, monitoring devices and solutions, and increasing adoption of the sleep apnea devices.
Within the research report, the market is segmented based on product type, end-user, and regional analysis. Each of these segments covers the market's snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
BMC Medical Co., Ltd
Braebon Medical Corporation
Cadwell Industries, Inc.
Cleveland Medical Devices Inc.
Dental Arts Laboratories, Inc.
Fisher & Paykel Healthcare Limited
General Electric Company
Inspire Medical Systems, Inc.
Itamar Medical Ltd.
Koninklijke Philips N.V.
Lowenstein Medical GmbH & Co. KG
Medical Depot, Inc.
Natus Medical Incorporated
PMD Device Solutions Limited
ProSomnus Sleep Technologies
Provent Sleep Therapy, LLC
Signifier Medical Technologies Limited
Smiths Group plc
Somnetics International, Inc.
VYAIRE MEDICAL, INC.
For more information about this report visit https://www.researchandmarkets.com/r/m5034c
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900